James R. Jett

James R. Jett

Professor of Medicine

Professor of Medicine,Emeritus
National Jewish Health, Denver Colorado
and
Chief Medical Officer
Oncimmune Ltd
Nottingham, United Kingdom

Dr. James Jett’s research interests focus on the screening and early detection of lung cancer and treatment of advanced stage lung cancer. As a principal investigator, co-investigator and consultant, Dr. Jett’s research has been funded by the National Institutes of Health and the National Cancer Institute, among other organizations. He was part of a research team that discovered how CT screening can be an effective tool to detect lung cancer early in high-risk patients.

Dr. Jett is board certified in Pulmonary Medicine. He was on the consulting staff of Mayo Clinic in Rochester, Minnesota for 28 years before moving to National Jewish Health in Denver, Colorado in 2010.  He has held professional memberships with numerous organizations such as the American Thoracic Society, International Association for the Study of Lung Cancer, American Society of Clinical Oncology, North Central Cancer Treatment Group, and the American College of Chest Physicians. He is currently on the Scientific Advisory Committee for the American Lung Association.

Dr. Jett was editor-in-chief of the Journal of Thoracic Oncology from 2006 to 2012.  He is was the Co-Editor of the Lung Cancer Section of the electronic textbook UP-TO-DATE from 2008-2017.

His academic honors include The 2013 IASLC Merit Award ,Clinical Educator Award from the ATS Assembly on Clinics Problems, 2014; selection for the 2015 Edition of Who’s Who in America; and the Lifetime Achievement Award from the ATS Assembly on Thoracic Oncology, 2015.